Published in Trans R Soc Trop Med Hyg on May 06, 1993
Dengue and dengue hemorrhagic fever. Clin Microbiol Rev (1998) 19.59
Etiology of interepidemic periods of mosquito-borne disease. Proc Natl Acad Sci U S A (2000) 4.75
Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Philos Trans R Soc Lond B Biol Sci (1999) 2.57
Advances in dengue diagnosis. Clin Diagn Lab Immunol (1996) 2.01
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
An in-depth analysis of original antigenic sin in dengue virus infection. J Virol (2010) 1.63
Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis (2013) 1.25
Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers. J Infect Dis (2010) 1.24
Two successive hepatitis C virus infections in an intravenous drug user. J Clin Microbiol (2000) 1.20
Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis. BMC Infect Dis (2012) 1.00
Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries. PLoS Negl Trop Dis (2015) 0.99
Serological evaluation of suspected West Nile virus human cases following its introduction during a dengue outbreak in Puerto Rico in 2007. Clin Vaccine Immunol (2011) 0.86
A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients. EBioMedicine (2017) 0.83
Sequential episodes of dengue--Puerto Rico, 2005-2010. Am J Trop Med Hyg (2014) 0.83
West nile virus: characteristics of an african virus adapting to the third millennium world. Open Virol J (2010) 0.83
Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelers. PLoS Negl Trop Dis (2015) 0.82
Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos, Mexico. Am J Trop Med Hyg (2014) 0.81
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity. Virology (2013) 0.81
Evaluation of an epitope-blocking enzyme-linked immunosorbent assay for the diagnosis of West Nile virus infections in humans. Clin Vaccine Immunol (2009) 0.80
Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans. Eur J Clin Microbiol Infect Dis (2007) 0.80
Enhanced West Nile virus surveillance in a dengue-endemic area--Puerto Rico, 2007. Am J Trop Med Hyg (2013) 0.77
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol (1992) 17.82
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Dengue and dengue haemorrhagic fever. Lancet (1998) 7.31
Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg (1984) 5.42
Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol (1994) 4.47
OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother (2000) 4.08
The potential health impacts of climate variability and change for the United States: executive summary of the report of the health sector of the U.S. National Assessment. Environ Health Perspect (2000) 3.86
Detecting artificial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1987) 3.58
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol (1997) 3.30
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg (1978) 3.08
Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J Clin Microbiol (2001) 3.06
Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ (1981) 2.99
West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis (2001) 2.90
An ELISA procedure for the diagnosis of dengue infections. J Virol Methods (1991) 2.86
Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. Am J Trop Med Hyg (1979) 2.64
Dengue in China: a clinical review. Bull World Health Organ (1993) 2.59
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. Am J Trop Med Hyg (1998) 2.18
Dengue 3 virus transmission in Africa. Am J Trop Med Hyg (1986) 2.17
Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun (1993) 2.11
A controlled trial of home-based acute psychiatric services. I: Clinical and social outcome. Br J Psychiatry (1993) 2.10
Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull World Health Organ (1983) 2.06
A case of natural concurrent human infection with two dengue viruses. Am J Trop Med Hyg (1985) 2.04
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother (2007) 2.04
Sylvatic transmission of arboviruses among Bornean orangutans. Am J Trop Med Hyg (2001) 2.02
Variation among geographic strains of Aedes albopictus in susceptibility to infection with dengue viruses. Am J Trop Med Hyg (1976) 1.99
Common occurrence of concurrent infections by multiple dengue virus serotypes. Am J Trop Med Hyg (1999) 1.97
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93
Dengue surveillance--United States, 1986-1992. MMWR CDC Surveill Summ (1994) 1.90
Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg (1996) 1.89
A simple technique for demonstrating transmission of dengue virus by mosquitoes without the use of vertebrate hosts. Am J Trop Med Hyg (1976) 1.81
Epidemic dengue 3 in central Java, associated with low viremia in man. Am J Trop Med Hyg (1981) 1.81
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis (2000) 1.74
Variation among goegraphic strains of Aedes albopictus in susceptibility to infection with chikungunya virus. Am J Trop Med Hyg (1976) 1.74
A survey for arboviral antibodies in sera of humans and animals in Lombok, Republic of Indonesia. Ann Trop Med Parasitol (1983) 1.64
Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol (2008) 1.63
West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations. Arch Virol Suppl (2004) 1.63
Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J Clin Microbiol (2000) 1.62
[Proteinuria and chronic renal failure in the coast of El Salvador: detection with low cost methods and associated factors]. Nefrologia (2005) 1.59
Use of the "CDC backpack aspirator" for surveillance of Aedes aegypti in San Juan, Puerto Rico. J Am Mosq Control Assoc (1994) 1.58
Epidemic dynamics revealed in dengue evolution. Mol Biol Evol (2009) 1.58
D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J (2000) 1.57
Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob Agents Chemother (2000) 1.56
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J Virol (2000) 1.56
Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995. Am J Trop Med Hyg (1998) 1.52
Doppler echocardiographic assessment of progression of aortic regurgitation. Am J Cardiol (1997) 1.52
Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study. Crit Care Med (2000) 1.50
Virological surveillance for dengue haemorrhagic fever in Indonesia using the mosquito inoculation technique. Bull World Health Organ (1979) 1.47
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
Comparative susceptibility of mosquito species and strains to oral and parenteral infection with dengue and Japanese encephalitis viruses. Am J Trop Med Hyg (1985) 1.44
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
Dengue and dengue hemorrhagic fever in Latin America and the Caribbean. Infect Dis Clin North Am (2000) 1.43
Changes in reticulocyte fractions during peripheral stem cell harvesting: role in monitoring stem cell collection. Bone Marrow Transplant (1996) 1.41
Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging diseases. Emerg Infect Dis (1996) 1.40
West Nile Virus in the New World: trends in the spread and proliferation of West Nile Virus in the Western Hemisphere. Zoonoses Public Health (2009) 1.39
Dengue transmission in two Puerto Rican communities in 1982. Am J Trop Med Hyg (1985) 1.38
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J Infect Dis (1988) 1.37
Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost (1997) 1.36
Study of anti-dengue NS1 antibody by western blot. J Med Virol (1990) 1.36
Epidemic dengue hemorrhagic fever in rural Indonesia. I. Virological and epidemiological studies. Am J Trop Med Hyg (1979) 1.36
First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. Am J Trop Med Hyg (1998) 1.35
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris) (2013) 1.33
Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. Clin Microbiol Infect (2005) 1.32
Dengue virus isolation in Indonesia, 1975-1978. Asian J Infect Dis (1979) 1.32
Dengue and dengue hemorrhagic fever. Pediatr Infect Dis J (1992) 1.29
Competitive displacement of Aedes (Stegomyia) Polynesiensis Marks by Aedes (Stegomyia) albopictus Skuse in laboratory populations. J Med Entomol (1970) 1.29
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect (2005) 1.27
Antigen capture ELISA for the identification of dengue viruses. J Virol Methods (1985) 1.27
Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. Bull World Health Organ (1985) 1.26
Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa. Antimicrob Agents Chemother (2006) 1.22
Epidemic dengue 2 in the city of Djibouti 1991-1992. Trans R Soc Trop Med Hyg (1996) 1.21
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Majorcan hospitals: high prevalence of the epidemic clone EMRSA-15. Clin Microbiol Infect (2007) 1.21
Epidemic polyarthritis (Ross River) virus infection in the Cook Islands. Am J Trop Med Hyg (1981) 1.20
Recording and analyzing high-density event-related potentials with infants. Using the Geodesic sensor net. Dev Neuropsychol (2001) 1.20
Epidemic of dengue-4 virus in Yap State, Federated States of Micronesia, and implication of Aedes hensilli as an epidemic vector. Am J Trop Med Hyg (1998) 1.18
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect (2007) 1.16
Dengue fever. Clin Dermatol (1989) 1.16
Epidemic dengue 4 in the Yucatán, México, 1984. Rev Inst Med Trop Sao Paulo (1994) 1.15
Surveillance for dengue and dengue hemorrhagic fever. Bull Pan Am Health Organ (1989) 1.15
Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis (2012) 1.14
The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. P R Health Sci J (1996) 1.13
Dengue type 1 epidemic with haemorrhagic manifestations in Fiji, 1989-90. Bull World Health Organ (1995) 1.13
Evaluation of an IgM immunoblot kit for dengue diagnosis. Am J Trop Med Hyg (1998) 1.12
Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients. Clin Microbiol Infect (2010) 1.10
Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus. J Virol (1995) 1.10
A dengue outbreak among camp participants in a Caribbean island, 1995. J Travel Med (2000) 1.09
A systematic review of outcome reporting in colorectal cancer surgery. Colorectal Dis (2013) 1.09
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Br J Cancer (2011) 1.08
Prospective cohort study to test the predictability of the Cardiff and Vale paediatric early warning system. Arch Dis Child (2008) 1.08
First report of Angiostrongylus cantonensis in Puerto Rico. Am J Trop Med Hyg (1986) 1.08
Development of visual acuity. Arch Dis Child (1973) 1.07
[Active surveillance for dengue and dengue hemorrhagic fever]. Bol Oficina Sanit Panam (1989) 1.05
Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase. J Clin Microbiol (2009) 1.04
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. Antimicrob Agents Chemother (2007) 1.04